Since the release of our Research Report on February 22nd, 2024, under the theme « BMCI : A significant room for cost saving » (Research Report-BMCI 2024), BMCI stock price increased by +16% to reach our initial target price of MAD 665 on January 13th, 2025.
In a very favorable banking environment, BMCI still has significant room for improvement in its profitability indicators, namely Cost-to-Income ratio (C/I ratio) and Net Income Group Share (NIGS). Thus, we maintain our BUY Recommendation on the Stock.
